We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Angioplasty Catheters for Below-the-Knee Arteries

By HospiMedica International staff writers
Posted on 24 Oct 2012
Two new catheters target the interventional treatment of atherosclerotically narrowed or occluded leg arteries below the knee. More...


The Amphirion Plus percutaneous transluminal angioplasty (PTA) catheter has an over-the-wire diameter of 0.3556 mm and possesses a wide inflation pressure range, which reaches up to 2026.5 kPa or 20 atmospheres (rated burst pressure) for all sizes--from 2 mm to 4 mm in diameter and through 120 mm in length. In addition to a versatile working range and size offering, the device’s fast inflation-deflation time provides an efficient angioplasty solution for common below-the-knee cases. The Amphirion Deep PTA Balloon Catheter, on the other hand, targets lesions in arteries below the ankle.

The design and features of the two devices reflect the distinct anatomical characteristics of the vessels that each one targets. Together, they represent a comprehensive solution for below-the-knee interventions, with the former targeting lesions between the knee and the ankle (where the blood vessels tend to be relatively straight and very often include calcifications), and the latter targeting lesions below the ankle (where the blood vessels tend to be more tortuous and smaller in diameter). The Amphirion catheters are products of Medtronic (Fridley, MN, USA), and have been approved by the US Food and Drug Administration (FDA).

“The Amphirion Plus Balloon features outstanding pushability and crossability characteristics and exceptional inflation-deflation performance,” said Nezar Falluji, MD, an interventional cardiologist at St. Joseph Cardiology Associates (Lexington, KY, USA), who performed the first case with the new device worldwide. “Its innovative design has made the Amphirion family of PTA balloons excellent tools in the management of critical limb ischemia and below-the-knee intervention.”

PAD below the knee often causes critical limb ischemia (CIL), in which poor blood circulation in the calf, ankle, foot, and toes can lead to ulcerated sores, amputation, and premature death. Risk factors include a history of smoking, poor diet, and lack of exercise. Its clinical impact on health varies by anatomical location.

Related Links:

Medtronic
St. Joseph Cardiology Associates



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.